Menu Close

Premium Partner Program

GSK’s Premium Partner Program is an exclusive program for accounts who are on our full portfolio contract and are compliant to the contract’s market share requirements (listed below). Qualifying members in the Premium Partner Program are provided exclusive member benefits that will maximize your contract agreement, partnership, and your vaccine program in its entirety.

PORTFOLIO CONTRACT (formerly The GSK PBG Plus program) offered through Access Vaccines provides the following benefits

  • Lowest national vaccine pricing on all GSK vaccines, including Shingrix and flu vaccines
  • 2% Prompt Pay discount when paying within 60 days
  • Discounts applied on each invoice
  • Free overnight shipping, no minimum purchase required
  • No minimums to meet per order, per month
  • With your affiliation with Access Vaccines there are no contracts to sign
  • Continue to place orders through, or through your distributor
  • Guarantee of no further price change for 2023
  • Guarantee of no price change for 2023 over 4% on select vaccines:
    • Pediarix, Infanrix, Kinrix, Rotarix, Menveo and Boostrix
  • Consistent pricing available through your preferred distribution channel, either indirectly via wholesaler/distributor or directly via
  • Consistent pricing for each location in your group on every order
  • Access to a dependable, customer aligned support team at GSK and Access Vaccines
    • Conducting vaccine contract reviews so you can make the best choices for your practice and more importantly your patients

Premium Partner Exclusive Benefits

Portfolio Market Share Requirements :

  1. Practices using Pediatric vaccines (DTap) must maintain a ≥80% GSK Market Share (Pediarix, Kinrix, Infanrix, Boostrix)
  2. Practices using Adult vaccines (TDap, Hepatitis) must maintain a ≥80% GSK Market Share (Boostrix, Havrix Adult, Engerix-B Adult, Twinrix).
  3. Practices using Meningococcal vaccines must maintain a ≥70% Market Share (Menveo, Bexsero)

GSK vaccines offered to practices located in the US:

Pediatric vaccines:

  • Pediarix (diphtheria and tetanus toxoids and acellular pertussis, hepatitis B and inactivated poliovirus)
  • Kinrix (diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus)
  • Infanrix (diphtheria and tetanus toxoids and acellular pertussis)
  • Rotarix (rotavirus)
  • Havrix (hepatitis A)
  • Engerix-B (hepatitis B)
  • Hiberix (haemophilus influenzae type b)

Adolescent vaccines:

  • Menveo (Meningococcal (Groups A, C, Y, and W-135))
  • Bexsero (Neisseria meningitidis serogroup B)

Adult vaccines:

  • Boostrix (active booster immunization against tetanus, diptheria, and pertussis)
  • Havrix AD (hepatitis A)
  • Energix-B AD (hepatitis B)
  • Priorix (MMR) 
  • Twinrix (hepatitis A and hepatitis B)
  • Shingrix (herpes zoster)